Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-09 Purchase | 2024-08-12 6:48 pm | PIERIS PHARMACEUTICALS INC. | PIRS | ADAR1 Capital Management LLC ADAR1 Partners LP 10% Owner | 6,000 | $15.39 | $92,326 | 15,067 (Indirect) | View |
| 2023-05-25 Purchase | 2023-05-30 4:21 pm | PIERIS PHARMACEUTICALS INC. | PIRS | KIRITSY CHRISTOPHER P Director | 10,000 | $0.85 | $8,500 | 20,000 (Direct) | View |
| 2022-05-13 Purchase | 2022-05-16 8:19 pm | PIERIS PHARMACEUTICALS INC. | PIRS | Demuth Tim Chief Medical Officer | 6,000 | $1.71 | $10,260 | 6,000 (Direct) | View |
| 2021-08-30 Sale | 2021-09-01 4:38 pm | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 38,400 | $5.1141 | $196,380 | 66,238 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-11-18 4:16 pm | N/A N/A | PIERIS PHARMACEUTICALS INC. | PIRS | Dellora Investments LP 10% Owner | 0 | $0 | 141,079 (Indirect) | View |
Ownership | 2024-07-31 7:26 pm | N/A N/A | PIERIS PHARMACEUTICALS INC. | PIRS | ADAR1 Capital Management LLC ADAR1 Partners LP 10% Owner | 0 | $0 | 138,641 (Indirect) | View |
| 2023-06-21 Option Award | 2023-06-23 4:47 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | Barbier Ann Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:46 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | GERAGHTY JAMES A Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:46 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | Kiener Peter A Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:46 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | KIRITSY CHRISTOPHER P Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:45 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | Richman Michael Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:45 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | Said Maya R. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:45 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | Sherman Matthew L Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2023-05-22 5:00 pm | N/A N/A | PIERIS PHARMACEUTICALS INC. | PIRS | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 39,154,557 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 5:39 pm | N/A 2033-02-24 | PIERIS PHARMACEUTICALS INC. | PIRS | Bures Thomas Chief Financial Officer | 249,080 | $0 | 249,080 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 5:35 pm | N/A 2033-02-24 | PIERIS PHARMACEUTICALS INC. | PIRS | Kaufmann Hitto Chief Scientific Officer | 249,080 | $0 | 249,080 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 5:31 pm | N/A 2033-02-24 | PIERIS PHARMACEUTICALS INC. | PIRS | Mousa Ahmed Chief Business Officer | 249,080 | $0 | 249,080 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 5:23 pm | N/A 2033-02-24 | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 249,080 | $0 | 249,080 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 5:09 pm | N/A 2033-02-24 | PIERIS PHARMACEUTICALS INC. | PIRS | Yoder Stephen S. Chief Executive Officer | 634,021 | $0 | 634,021 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:04 pm | N/A 2032-06-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Barbier Ann Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:04 pm | N/A 2032-06-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Said Maya R. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:03 pm | N/A 2032-06-22 | PIERIS PHARMACEUTICALS INC. | PIRS | GERAGHTY JAMES A Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:03 pm | N/A 2032-06-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Kiener Peter A Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:03 pm | N/A 2032-06-22 | PIERIS PHARMACEUTICALS INC. | PIRS | KIRITSY CHRISTOPHER P Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:02 pm | N/A 2032-06-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Richman Michael Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:02 pm | N/A 2032-06-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Sherman Matthew L Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 4:50 pm | N/A 2032-02-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Demuth Tim Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 4:48 pm | N/A 2032-02-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Mousa Ahmed Chief Business Officer | 215,819 | $0 | 215,819 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 4:47 pm | N/A 2032-02-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 215,819 | $0 | 215,819 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 4:46 pm | N/A 2032-02-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Bures Thomas Chief Financial Officer | 215,819 | $0 | 215,819 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 4:45 pm | N/A 2032-02-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Kaufmann Hitto SVP, Chief Scientific Officer | 215,819 | $0 | 215,819 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 4:44 pm | N/A 2032-02-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Yoder Stephen S. Chief Executive Officer | 625,874 | $0 | 625,874 (Direct) | View |
Ownership | 2021-10-21 5:08 pm | N/A 2026-01-21 | PIERIS PHARMACEUTICALS INC. | PIRS | Mousa Ahmed Chief Business Officer | 0 | $0 | 545,000 (Direct) | View |
| 2021-08-30 Exercise | 2021-09-01 4:38 pm | N/A N/A | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 38,400 | $1.52 | 66,238 (Direct) | View |
| 2021-08-30 Exercise | 2021-09-01 4:38 pm | N/A 2026-02-12 | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 38,400 | $0 | 66,238 (Direct) | View |
| 2021-08-01 Option Award | 2021-08-03 4:19 pm | N/A 2031-08-01 | PIERIS PHARMACEUTICALS INC. | PIRS | Demuth Tim Chief Medical Officer | 360,000 | $0 | 360,000 (Direct) | View |
Ownership | 2021-08-03 4:09 pm | N/A N/A | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 0 | $0 | 717,888 (Direct) | View |
| 2021-06-25 Option Award | 2021-06-29 5:38 pm | N/A 2031-06-25 | PIERIS PHARMACEUTICALS INC. | PIRS | Sherman Matthew L Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-25 Option Award | 2021-06-29 5:36 pm | N/A 2031-06-25 | PIERIS PHARMACEUTICALS INC. | PIRS | Said Maya R. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-25 Option Award | 2021-06-29 5:33 pm | N/A 2031-06-25 | PIERIS PHARMACEUTICALS INC. | PIRS | Richman Michael Director | 40,000 | $0 | 40,000 (Direct) | View |